Christer Ahlberg about the present and the future of Cinclus Pharma
Christer Ahlberg, CEO of Cinclus Pharma since June 2021, shares his thoughts about the company's current position and future vision.
Read more
News
Check out the latest news from Cinclus Pharma
Life Science Sweden interviews Kjell Andersson, CSO
During Life Science Sweden's conference "Pharma Outsourcing", Kjell Andersson, CSO at Cinclus Pharma, was interviewed about our drug candidate linaprazan glurate, which is an acid secretion inhibitor, a so-called P-CAB.
Read more
From startup to potential global game-changer
The story of Cinclus Pharma started when a chemist, a pharmacologist, a gastroenterologist, and three experts in finance and business development came together to address the unmet medical need for reflux disease treatment.
Read more